AstraZeneca bets $247m on AI company developing cancer drug
AstraZeneca has committed $247 million to fund AI drug discovery company Absci’s efforts to develop an antibody for cancer. Absci…
Sign up for our weekly newsletter and receive exclusive access to DailyAI's Latest eBook: 'Mastering AI Tools: Your 2024 Guide to Enhanced Productivity'.
*By subscribing to our newsletter you accept our Privacy Policy and our Terms and Conditions